PD-160874

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamePD-160874
Drug Alias NamePD-160874
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEndothelin receptor type A antagonistsEndothelin receptor type B antagonists
TargetsEndothelin receptor type BEndothelin receptor type A
Therapy Area/IndicationsCardiovascular DiseasesAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesParke-Davis Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesParke-Davis Corp
Active IndicationsN/A
Inactive IndicationsCardiovascular DiseasesAsthma

Other Information

ATC CodeN/A
Related LinksN/A